Authors:
Fenig, E
Kanfi, Y
Wang, Q
Beery, E
Livnat, T
Wasserman, L
Lilling, G
Yahalom, J
Wieder, R
Nordenberg, J
Citation: E. Fenig et al., Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor, BREAST CANC, 70(1), 2001, pp. 27-37
Authors:
Wang, Q
Lee, D
Sysounthone, V
Chandraratna, RAS
Christakos, S
Korah, R
Wieder, R
Citation: Q. Wang et al., 1,25-dihydroxyvitamin D-3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects, BREAST CANC, 67(2), 2001, pp. 157-168
Authors:
Wang, Q
Yang, W
Uytingco, MS
Christakos, S
Wieder, R
Citation: Q. Wang et al., 1,25-dihydroxyvitamin D-3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death, CANCER RES, 60(7), 2000, pp. 2040-2048
Authors:
Korah, RM
Sysounthone, V
Golowa, Y
Wieder, R
Citation: Rm. Korah et al., Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells, CANCER RES, 60(3), 2000, pp. 733-740
Authors:
Fenig, E
Livnat, T
Sharkon-Polak, S
Wasserman, L
Beery, E
Lilling, G
Yahalom, J
Wieder, R
Nordenberg, J
Citation: E. Fenig et al., Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells, J CANC RES, 125(10), 1999, pp. 556-562
Authors:
Maloof, P
Wang, Q
Wang, H
Stein, D
Denny, TN
Yahalom, J
Fenig, E
Wieder, R
Citation: P. Maloof et al., Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells, BREAST CANC, 56(2), 1999, pp. 153-167